ストックスクリーナーアプリを入手
7.11
0.56%
-0.04
アフターアワーズ：
3.43
-3.68
-51.76%
前日終値:
$7.15
開ける：
$7.18
24時間の取引高:
310.34K
Relative Volume:
0.42
時価総額：
$1.05B
収益：
$342.81M
当期純損益:
$97.67M
株価収益率:
11.57
EPS:
0.6145
ネットキャッシュフロー:
$50.46M
1週間 パフォーマンス:
+1.28%
1か月 パフォーマンス:
+12.32%
6か月 パフォーマンス:
-15.36%
1年 パフォーマンス:
+13.40%
1日の値動き範囲:
$7.09
$7.22
1週間の範囲:
$6.89
$7.45
52週間の値動き範囲:
$5.47
$10.14
Mimedx Group Inc Stock (MDXG) Company Profile
名前
Mimedx Group Inc
セクター
電話
(770) 651-9100
住所
1775 W OAK COMMONS COURT, NE, MARIETTA
MDXG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.95 | 1.26B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.35 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.56 | 111.10M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1599 | 329.13M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.32 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-03-07 | 開始されました | Lake Street | Buy |
| 2023-10-27 | 開始されました | Craig Hallum | Buy |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2021-07-26 | 開始されました | Northland Capital | Outperform |
| 2021-03-19 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Mimedx Group Inc (MDXG) 最新ニュース
Does MiMedx Group Inc. have consistent dividend growthJuly 2025 PostEarnings & Long-Term Investment Growth Plans - kangso.co.kr
Is MiMedx Group Inc. stock heavily shortedQuarterly Profit Summary & Fast Gaining Stock Reports - newsyoung.net
US Ophthalmology Amniotic Membrane Market to Reach $7.35B - openPR.com
What makes MiMedx Group Inc. stock price move sharplyMulti-Fold Return Candidates - mustnews.co.kr
There May Be Reason For Hope In MiMedx Group's (NASDAQ:MDXG) Disappointing Earnings - Yahoo Finance
Clover Health and MiMedx Group Receive Bullish Analyst Sentiments - AInvest
Why MiMedx Group Inc. stock attracts strong analyst attentionShort Term High Yield Stock Tips for Active Traders - metal.it
Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and MiMedx Group (MDXG) - The Globe and Mail
MiMedx Group Inc. Reports Record Earnings and Growth - TipRanks
MiMedx raises full-year revenue growth outlook to low double digits as momentum builds post-record quarter - MSN
Is MiMedx Group Inc. a good long term investmentFree Consultation - Jammu Links News
What drives MiMedx Group Inc. stock priceBuild wealth faster with consistent investment plans - Jammu Links News
Published on: 2025-08-04 04:52:32 - Jammu Links News
What are analysts’ price targets for MiMedx Group Inc. in the next 12 monthsHigh-yield investments - Jammu Links News
MiMedx Group Inc. Stock Analysis and ForecastCapitalize on stocks with high profit margins - Jammu Links News
When is MiMedx Group Inc. stock expected to show significant growthAchieve breakthrough financial results - Jammu Links News
Should I hold or sell MiMedx Group Inc. stock in 2025Consistently superior profits - Jammu Links News
What institutional investors are buying MiMedx Group Inc. stockCapitalize on high-yield stock opportunities - Jammu Links News
How does MiMedx Group Inc. generate profit in a changing economyHarness the power of proven investment plans - Jammu Links News
What catalysts could drive MiMedx Group Inc. stock higher in 2025Free Investment Community - Jammu Links News
What is the dividend policy of MiMedx Group Inc. stockAchieve fast wealth growth with smart picks - Jammu Links News
Is it the right time to buy MiMedx Group Inc. stockMaximize gains with data-driven stock picks - Jammu Links News
What are the latest earnings results for MiMedx Group Inc.Achieve explosive financial results today - Jammu Links News
What is the risk reward ratio of investing in MiMedx Group Inc. stockAchieve breakthrough results with expert guidance - Jammu Links News
MiMedx Exceeds Q2 Revenue Expectations with Double-Digit Growth, Achieving Highest Quarterly Net Sales to Date. - AInvest
MiMedx Q2 2025 Earnings: EPS of $0.06 Beats Estimates, Revenue Hits $99 Million Surpassing Projections - AInvest
MiMedx Group Anticipates Improved EBITDA Margin for FY25, Projects Low Double-Digit Annual Net Sales Growth - AInvest
MiMedx Group, Inc. (NASDAQ:MDXG) Q2 2025 Earnings Call Transcript - Insider Monkey
MiMedx Group Reports Record Q2 2025 Financial Results - The Globe and Mail
MiMedx Group Inc. Achieves Impressive Q2 Financial ResultsNews and Statistics - IndexBox
MiMedx Group 2025 Q2 Earnings Mixed Results with Net Income Down 45% - AInvest
MiMedx stock price target raised to $12 from $11 at Cantor Fitzgerald - Investing.com Australia
MiMedx Price Target Raised to $12 Amid Q2 Revenue Beat and 2025 Guidance Increase - AInvest
MiMedx Group Stock Soars 11.35% on Record Q2 Earnings - AInvest
MiMedx: Q2 Earnings Snapshot - Connecticut Post
Published on: 2025-07-31 13:51:17 - beatles.ru
MiMedx Group Inc (MDXG) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
MiMedx Group Inc (MDXG) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
MiMedx Reports Record Q2 2025 Financial Results - TipRanks
MiMedx Raises Full-Year Revenue Growth Outlook to Low Double Digits, Posting Record Q2 Results - AInvest
MiMedx's Q2 2025 Earnings Call: Contradictions on Market Share, Regulations, and Growth Prospects - AInvest
MiMedx Partners With Vaporox To Expand Wound Care Portfolio And Invests In VHT Technology - Nasdaq
Mimedx Group Inc (MDXG) 財務データ
収益
当期純利益
現金流量
EPS
Mimedx Group Inc (MDXG) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Maersk-Moller Kimberly | Chief Commercial Officer |
Mar 17 '25 |
Sale |
8.04 |
1,759 |
14,142 |
309,077 |
| Hulse William Frank IV | General Counsel and CAO |
Mar 13 '25 |
Sale |
7.89 |
54,596 |
430,762 |
440,178 |
| Maersk-Moller Kimberly | Chief Commercial Officer |
Mar 13 '25 |
Sale |
7.89 |
4,106 |
32,396 |
310,836 |
| Hulse William Frank IV | General Counsel and CAO |
Mar 10 '25 |
Sale |
7.80 |
81,446 |
635,279 |
494,774 |
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):